Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

2 results

Filter Results By

Filter Applied. Clear All

Latest Posts

June 3, 2024 Abortion Reporting: Arkansas (2023) Abortion Reporting: Arkansas (2023) May 29, 2024 Abortion Reporting: West Virginia (2023) Abortion Reporting: West Virginia (2023) May 29, 2024 Abortion Reporting: Indiana (2023) Abortion Reporting: Indiana (2023)
Reset All Filters
2 results
featured-image

United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

CLI's VP of Medical Affairs Ingrid Skop, together with Calum Miller, MD, and Kevin Duffy, MPH, recently published an article in Issues in Law & Medicine arguing that decisions by the FDA to pull back regulations on the abortion drug mifepristone in part relied on "flawed studies with significantly undercounted complications" from the U.K.

Ingrid Skop, M.D., FACOG
May 23, 2024
ClosePlease login

Misleading Statements About “Life of the Mother” Exceptions in Pro-life Laws Require Correction

Recently CLI scholars Ingrid Skop, M.D. and Mary Harned, J.D. published a rebuttal in Issues in Law & Medicine to a series of misleading statements made in an article that appeared in the journal Obstetrics & Gynecology.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image